This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2025. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | universityofmarylandbaltimore |
| Website | http://www.umaryland.edu |
| Twitter username | umbaltimore |
| Wikipedia page | https://en.wikipedia.org/wiki/University_of_Maryland,_Baltimore |
| Instagram username | umbaltimore |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 50 | 1,062,438 | 3,846,537 | -104,462 | 50,000 | 100,000 | 249,289 | 622,606 | 1,062,438 | 1,442,723 | 2,473,837 | 4,800,000 | 10,499,702 | 36,934,066 |
| Global health | 41 | 1,341,337 | 4,391,980 | -104,462 | 99,999 | 100,000 | 536,466 | 839,880 | 1,341,337 | 2,354,298 | 3,499,799 | 5,621,367 | 15,000,000 | 36,934,066 |
| Science | 3 | 44,942 | 104,744 | 20,000 | 20,000 | 20,000 | 20,000 | 44,942 | 44,942 | 44,942 | 249,289 | 249,289 | 249,289 | 249,289 |
| Nutrition | 1 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
| Sanitation | 4 | 698,673 | 2,599,672 | 360,120 | 360,120 | 360,120 | 698,673 | 698,673 | 698,673 | 1,299,704 | 1,299,704 | 8,040,190 | 8,040,190 | 8,040,190 |
| Science and Technology | 1 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 | 1,442,723 |
| Donor | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 190,569,883.95 | 3,000,000.00 | 791,976.09 | 42,333,989.00 | 2,473,837.00 | 29,813,875.00 | 3,008,242.00 | 5,485,363.00 | 38,824,628.00 | 5,008,596.00 | 10,549,702.00 | 666,606.00 | 20,621,367.00 | 27,991,702.86 |
| Arnold Ventures (filter this donee) | 1,442,723.00 | 0.00 | 1,442,723.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sloan Foundation (filter this donee) | 314,231.00 | 0.00 | 0.00 | 269,289.00 | 0.00 | 44,942.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 192,326,837.95 | 3,000,000.00 | 2,234,699.09 | 42,603,278.00 | 2,473,837.00 | 29,858,817.00 | 3,008,242.00 | 5,485,363.00 | 38,824,628.00 | 5,008,596.00 | 10,549,702.00 | 666,606.00 | 20,621,367.00 | 27,991,702.86 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 50) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 3,000,000.00 | 15 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to accelerate introduction of typhoid conjugate vaccine into Gavi-eligible countries and reduce the global burden of typhoid fever; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 99,999.00 | 44 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to plan for biannual azithromycin distribution in Mali.. Mali Planning Grant for National Implementation of Biannual Azithromycin Administration. Investment start date: 11/30/2017 to end date: 1/1/2019. Grantee name: University of Maryland, Baltimore; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 796,439.09 | 29 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to accelerate introduction of typhoid conjugate vaccine into Gavi-eligible countries and reduce the global burden of typhoid fever; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -104,462.00 | 50 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to prepare the GEMS-1 and GEMS-1A repositories and generate a GEMS-1 nucleic acids archive for access by the wider scientific community; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Arnold Ventures | 1,442,723.00 | 21 | Science and Technology | https://www.arnoldventures.org/grants/ | -- | To improve transparency in clinical trials. Affected states: Maryland. | |
| Bill and Melinda Gates Foundation | 3,499,799.00 | 14 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to understand what drives sustained low-level typhoid transmission in Santiago, Chile, where typhoid was once highly endemic, and to use these lessons to assess the feasibility of typhoid elimination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 512,227.00 | 34 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to raise awareness and support in Myanmar for scaling Targeted Parasite Elimination (TPE) via diplomatic effort in the civilian and military sectors and pilot scale evidence development required by local stakeholders to eventually go to scale; Aid type: Project-type interventions. Affected countries: Myanmar. | |
| Bill and Melinda Gates Foundation | 36,934,066.00 | 1 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to accelerate introduction of typhoid conjugate vaccine into Gavi-eligible countries and reduce the global burden of typhoid fever; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,237,897.00 | 25 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to understand the impact of rotavirus vaccine introduction on rotavirus gastroenteritis and other key diarrheal disease pathogens in sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 150,000.00 | 37 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the 10th iteration of a biannual symposium for dissemination of information on rotavirus disease and epidemiology, clinical developments and rotavirus vaccine introduction in Africa, continuing to enable rotavirus scientists, clinicians, policy; Aid type: Project-type interventions. Affected regions: Africa. | |
| Sloan Foundation | 249,289.00 | 36 | Science/Microbiology of the Built Environment | https://sloan.org/grant-detail/8213 | -- | Grant investigator: Lynn Schriml; to support a scientific meeting celebrating the accomplishments of the MoBE program in 2017. | |
| Sloan Foundation | 20,000.00 | 49 | Science/Microbiology of the Built Environment | https://sloan.org/grant-detail/7732 | -- | Grant investigator: Lynn Schriml; to conduct planning activities for the MoBE 2017 meeting. | |
| Bill and Melinda Gates Foundation | 2,473,837.00 | 16 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop human experimental challenge models in which adult volunteers will be given the protozoan pathogen Cryptosporidium hominis in order to lay a rational foundation for vaccine development; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,800,000.00 | 11 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support a clinical study of the impact of rotavirus vaccine introduction on moderate to severe diarrhea among children ages 0–59 months in Gambia, Kenya, and Mali; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 18,377,831.00 | 3 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to understand the impact of rotavirus vaccine introduction on rotavirus gastroenteritis and other key diarrheal disease pathogens in sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,626,240.00 | 12 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to raise awareness and support in Myanmar for scaling Targeted Parasite Elimination (TPE) via diplomatic effort in the civilian and military sectors and pilot scale evidence development required by local stakeholders to eventually go to scale; Aid type: Project-type interventions. Affected countries: Myanmar. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 38 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to find new treatments to repair the damage caused by repeat intestinal infections in young children from developing countries by generating an in vitro model of the gut using stem cells and immune cells; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,341,337.00 | 23 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to estimate incidence of influenza-like illness and lab confirmed influenza in pregnant and post-partum women and their infants and conduct controlled trials to determine safety and effectiveness of maternal flu vaccine for women and their infants; Aid type: Project-type interventions. Affected countries: Mali. | |
| Bill and Melinda Gates Foundation | 568,467.00 | 32 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to develop broadly effective vaccines and interventions against enteric infections by conducting multi-country case-control studies using standardized methods to measure the etiology and burden of diarrhea among children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Mozambique|Bangladesh|Gambia (the)|India|Mali|Kenya. | |
| Sloan Foundation | 44,942.00 | 47 | Science/Microbiology of the Built Environment | https://sloan.org/grant-detail/7790 | -- | Grant investigator: Lynn Schriml; to foster metadata collection and analysis across the Microbiology of the Built Environment program. | |
| Bill and Melinda Gates Foundation | 1,409,338.00 | 22 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to prepare the GEMS-1 and GEMS-1A repositories and generate a GEMS-1 nucleic acids archive for access by the wider scientific community; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,062,438.00 | 26 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to develop broadly effective vaccines and interventions against enteric infections by conducting multi-country case-control studies using standardized methods to measure the etiology and burden of diarrhea among children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Mozambique|Bangladesh|Gambia (the)|India|Mali|Kenya. | |
| Bill and Melinda Gates Foundation | 536,466.00 | 33 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to test the feasibility of a rapid and senstitive diagnostic assay that can ultimately be developed into a hand-held point-of-care device that detects Salmonella in blood; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,496,224.00 | 20 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to estimate incidence of influenza-like illness and lab confirmed influenza in pregnant and post-partum women and their infants and conduct controlled trials to determine safety and effectiveness of maternal flu vaccine for women and their infants; Aid type: Project-type interventions. Affected countries: Mali. | |
| Bill and Melinda Gates Foundation | 3,889,139.00 | 13 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to develop broadly effective vaccines and interventions against enteric infections by conducting multi-country case-control studies using standardized methods to measure the etiology and burden of diarrhea among children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Mozambique|Bangladesh|Gambia (the)|India|Mali|Kenya. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 38 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop an inexpensive, safe, and effective oral vaccine against invasive Salmonella disease using gas-filled bacterial vesicles.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 884,835.00 | 27 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to test the feasibility of a rapid and senstitive diagnostic assay that can ultimately be developed into a hand-held point-of-care device that detects Salmonella in blood; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 6,965,308.00 | 9 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to define the relationship between anti-HIV-1 Env antibody specificity and Fc-mediated effector function to guide HIV-1 vaccine development; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 95,086.00 | 45 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to support the GEMS International Scientific Advisory Committee Meeting. GEMS ISAC for 2011. Investment start date: 7/20/2011 to end date: 11/25/2011. Grantee name: University of Maryland, Baltimore; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 10,347,537.00 | 7 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to develop broadly effective vaccines and interventions against enteric infections by conducting multi-country case-control studies using standardized methods to measure the etiology and burden of diarrhea among children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Mozambique|Bangladesh|Gambia (the)|India|Mali|Kenya. | |
| Bill and Melinda Gates Foundation | 16,804,024.00 | 4 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the clinical development of a novel HIV protein construct that presents CD4 induced epitopes; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 38 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to identify surface biomarkers of HIV latently infected cells by comparing membrane proteomes of latently infected and uninfected cells.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,299,704.00 | 24 | Sanitation/basic sanitation | https://iatiregistry.org/publisher/bmgf | -- | to develop an understanding of menstrual management practices, needs, and product demand to inform sanitation planning in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 698,673.01 | 30 | Sanitation/basic sanitation | https://iatiregistry.org/publisher/bmgf | -- | to guide development of broadly effective vaccines against enteric infections by measuring etiology and burden of severe diarrhea among young children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|Africa|Asia. | |
| Bill and Melinda Gates Foundation | 1,629,460.99 | 19 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to guide development of broadly effective vaccines against enteric infections by measuring etiology and burden of severe diarrhea among young children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|Africa|Asia. | |
| Bill and Melinda Gates Foundation | 2,354,298.00 | 17 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to improve understanding of the causes of severe diarrhea amoung children in high mortality areas; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,354,298.00 | 17 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to improve understanding of the causes of severe diarrhea amoung children in high mortality areas; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 38 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to integrate characteristics of heat shock proteins from thermophilic organisms, which live at relatively high temperatures, into attenuated bacterial vaccines to enhance viability and immunogenicity these vaccines during the freeze-drying process; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 38 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to test the ability of a novel synthetic peptide, AT1002, to induce the pathways within the mucosa to increase the delivery of antigens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 38 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a diagnostic platform based on seed germination by integrating DNA amplification with the expression of reporter proteins in plant seeds to aid in the detection of infectious diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 10,499,702.00 | 6 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to estimate incidence of influenza-like illness and lab confirmed influenza in pregnant and post-partum women and their infants and conduct controlled trials to determine safety and effectiveness of maternal flu vaccine for women and their infants; Aid type: Project-type interventions. Affected countries: Mali. | |
| Bill and Melinda Gates Foundation | 50,000.00 | 46 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the 12th Annual International Meeting of the Institute of Human Virology: Celebrating 25 Years after Discovering HIV as the Cause of AIDS; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 622,606.00 | 31 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to introduce and monitor the effects of Haemophilus influenzae type b (Hib) conjugate vaccine in high-risk infant populations in Mali, West Africa; Aid type: Project-type interventions. Affected countries: Mali. | |
| Bill and Melinda Gates Foundation | 44,000.00 | 48 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to support the 11th Annual International Meeting of the Institute of Human Virology; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 15,000,000.00 | 5 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop a vaccine in both developing and developed nations that prevents the transmission of HIV; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,621,367.00 | 10 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop rapid, high throughput methods to ascertain the burden and etiology of enteric disease in developing countries; Aid type: Project-type interventions. Affected regions: Asia|Africa. | |
| Bill and Melinda Gates Foundation | 360,120.00 | 35 | Sanitation/basic sanitation | https://iatiregistry.org/publisher/bmgf | -- | to guide development of broadly effective vaccines against enteric infections by measuring etiology and burden of severe diarrhea among young children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|Africa|Asia. | |
| Bill and Melinda Gates Foundation | 839,880.00 | 28 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to guide development of broadly effective vaccines against enteric infections by measuring etiology and burden of severe diarrhea among young children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|Africa|Asia. | |
| Bill and Melinda Gates Foundation | 18,751,512.83 | 2 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to guide development of broadly effective vaccines against enteric infections by measuring etiology and burden of severe diarrhea among young children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|Africa|Asia. | |
| Bill and Melinda Gates Foundation | 8,040,190.03 | 8 | Sanitation/basic sanitation | https://iatiregistry.org/publisher/bmgf | -- | to guide development of broadly effective vaccines against enteric infections by measuring etiology and burden of severe diarrhea among young children in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|Africa|Asia. |